COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City. Academic Article uri icon

Overview

abstract

  • Childhood cancer survivors are at increased risk for treatment-related late effects; data are lacking on how coronavirus disease 2019 (COVID-19) infection impacts this cohort. We assessed COVID-19-related symptoms, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG seroprevalence, and rate of COVID-19-related hospitalization among 321 asymptomatic survivors of childhood cancer or transplantation seen for routine long-term follow-up between May and September 2020 in a New York City tertiary cancer center. While 10.9% (n = 35) reported possible COVID-19-related symptoms, 7.8% (n = 20) of those tested had positive SARS-CoV-2 IgG, and one patient (0.3%) required COVID-19-related hospitalization. This report suggests that childhood cancer survivors appear to be at relatively low risk for COVID-19 complications.

publication date

  • December 23, 2020

Research

keywords

  • Antibodies, Viral
  • COVID-19
  • Cancer Survivors
  • Hematologic Neoplasms

Identity

PubMed Central ID

  • PMC7883208

Scopus Document Identifier

  • 85098005820

Digital Object Identifier (DOI)

  • 10.1002/pbc.28857

PubMed ID

  • 33355979

Additional Document Info

volume

  • 68

issue

  • 3